Brendan Smith
Stock Analyst at TD Cowen
(1.76)
# 3,370
Out of 5,115 analysts
16
Total ratings
45.45%
Success rate
1.72%
Average return
Main Sectors:
Stocks Rated by Brendan Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNA Ginkgo Bioworks Holdings | Maintains: Buy | $14 → $12 | $8.97 | +33.78% | 2 | Jan 8, 2026 | |
| TWST Twist Bioscience | Maintains: Buy | $32 → $43 | $41.07 | +4.70% | 1 | Jan 8, 2026 | |
| SLP Simulations Plus | Maintains: Hold | $16 → $19 | $16.89 | +12.49% | 2 | Jan 8, 2026 | |
| SDGR Schrödinger | Maintains: Buy | $33 → $24 | $13.97 | +71.80% | 1 | Jan 8, 2026 | |
| CTKB Cytek Biosciences | Maintains: Buy | $4 → $5 | $5.00 | - | 1 | Jan 8, 2026 | |
| AZTA Azenta | Maintains: Hold | $35 → $39 | $38.88 | +0.31% | 1 | Jan 8, 2026 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $79 → $90 | $71.71 | +25.51% | 3 | Jan 8, 2026 | |
| NVAX Novavax | Maintains: Hold | $8 → $7 | $8.85 | -20.86% | 2 | Nov 4, 2025 | |
| WST West Pharmaceutical Services | Initiates: Buy | $350 | $231.12 | +51.44% | 1 | Oct 29, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Outperform | n/a | $69.33 | - | 1 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $21.74 | - | 1 | Dec 5, 2022 |
Ginkgo Bioworks Holdings
Jan 8, 2026
Maintains: Buy
Price Target: $14 → $12
Current: $8.97
Upside: +33.78%
Twist Bioscience
Jan 8, 2026
Maintains: Buy
Price Target: $32 → $43
Current: $41.07
Upside: +4.70%
Simulations Plus
Jan 8, 2026
Maintains: Hold
Price Target: $16 → $19
Current: $16.89
Upside: +12.49%
Schrödinger
Jan 8, 2026
Maintains: Buy
Price Target: $33 → $24
Current: $13.97
Upside: +71.80%
Cytek Biosciences
Jan 8, 2026
Maintains: Buy
Price Target: $4 → $5
Current: $5.00
Upside: -
Azenta
Jan 8, 2026
Maintains: Hold
Price Target: $35 → $39
Current: $38.88
Upside: +0.31%
Halozyme Therapeutics
Jan 8, 2026
Maintains: Buy
Price Target: $79 → $90
Current: $71.71
Upside: +25.51%
Novavax
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $7
Current: $8.85
Upside: -20.86%
West Pharmaceutical Services
Oct 29, 2025
Initiates: Buy
Price Target: $350
Current: $231.12
Upside: +51.44%
Arrowhead Pharmaceuticals
Jul 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $69.33
Upside: -
Dec 5, 2022
Initiates: Outperform
Price Target: n/a
Current: $21.74
Upside: -